IMMUNE THROMBOCYTOPENIA (ITP)

Clinical trials for IMMUNE THROMBOCYTOPENIA (ITP) explained in plain language.

Never miss a new study

Get alerted when new IMMUNE THROMBOCYTOPENIA (ITP) trials appear

Sign up with your email to follow new studies for IMMUNE THROMBOCYTOPENIA (ITP), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 8 Not yet recruiting 3 Completed 1 Terminated 1

New drug tested for stubborn blood disorder

Disease control Completed

This study tested an experimental drug called BIVV020 in 12 adults with persistent or chronic immune thrombocytopenia (ITP), a condition where the immune system attacks platelets. The main goal was to see if BIVV020 could safely help increase and maintain platelet counts over a l…

Matched conditions: IMMUNE THROMBOCYTOPENIA (ITP)

Phase: PHASE2 • Sponsor: Bioverativ, a Sanofi company • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

IMMUNE THROMBOCYTOPENIA (ITP)

Get alerted when new IMMUNE THROMBOCYTOPENIA (ITP) trials appear

New drug tested for stubborn blood disorder